StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
248
This month
3
This year
21
Publishing Date
2024 - 03 - 20
2
2024 - 02 - 27
2
2024 - 02 - 15
2
2024 - 02 - 07
2
2023 - 11 - 29
3
2023 - 11 - 28
2
2023 - 11 - 08
3
2023 - 11 - 07
2
2023 - 11 - 02
4
2023 - 10 - 23
2
2023 - 10 - 22
2
2023 - 09 - 06
2
2023 - 08 - 03
3
2023 - 07 - 20
2
2023 - 07 - 18
3
2023 - 07 - 04
2
2023 - 05 - 09
2
2023 - 03 - 30
2
2023 - 03 - 29
2
2022 - 10 - 26
2
2022 - 10 - 18
2
2022 - 07 - 28
2
2022 - 04 - 27
2
2022 - 04 - 19
2
2022 - 03 - 29
2
2022 - 02 - 28
2
2022 - 02 - 16
2
2022 - 02 - 02
2
2021 - 11 - 12
2
2021 - 11 - 10
3
2021 - 11 - 09
2
2021 - 10 - 19
2
2021 - 08 - 31
2
2021 - 08 - 12
3
2021 - 08 - 11
4
2021 - 08 - 09
2
2021 - 08 - 05
3
2021 - 07 - 21
2
2021 - 07 - 08
2
2021 - 06 - 12
2
2021 - 05 - 17
2
2021 - 05 - 11
4
2021 - 05 - 06
1
2021 - 05 - 05
1
2021 - 05 - 03
1
2021 - 04 - 28
1
2021 - 04 - 22
1
2021 - 04 - 20
3
2021 - 04 - 13
1
2021 - 03 - 23
1
2021 - 03 - 22
1
2021 - 03 - 19
2
2021 - 03 - 18
1
2021 - 03 - 17
1
2021 - 03 - 11
1
2021 - 03 - 09
1
2021 - 03 - 08
1
2021 - 03 - 04
1
2021 - 01 - 26
2
2021 - 01 - 25
2
Sector
Commercial services
2
Communications
4
Consumer non-durables
1
Consumer services
1
Electronic technology
3
Finance
6
Health care and social assistance
1
Health services
1
Health technology
248
Manufacturing
10
N/a
13
Process industries
1
Producer manufacturing
1
Technology services
5
Transportation
3
Tags
Active
3
Africa
2
Antibody
4
Asia
4
Balversa
2
Biocapital
2
Bioforest
3
Biotech
3
Biotech-bay
3
Biotech-beach
8
Biotechnology
3
Bladder
4
Business
14
Cancer
6
Clinical-trials-phase-ii
5
Clinical-trials-phase-iii
5
Conference
5
Covid
9
Covid-19
7
Diagnostic
3
Diagnostics
3
Disease
7
Earnings
31
Employee
3
Financial
51
Financial results
39
Genetown
3
Growth
7
Il-23
3
Jnj-2113
4
Milestone
3
Money
6
N/a
151
Pharm-country
9
Pharma
14
Pharmaceuticals
6
Phase 1
5
Phase 2
7
Phase 2b
3
Phase 3
6
Positive
19
Psoriasis
4
Report
14
Research
3
Response
6
Results
218
Risk
3
Royalty
8
Show
5
Study
12
Therapeutics
13
Therapy
4
Topline
6
Treatment
6
Tremfya
3
Trial
10
Ulcerative colitis
3
Update
26
Vaccine
12
Year
31
Entities
2seventy bio, inc.
1
Abbvie inc.
12
Ac immune sa
2
Adagio therapeutics inc
1
Adma biologics inc
1
Agile therapeutics, inc.
2
Akari therapeutics plc
1
Albemarle corporation
1
Alkermes plc
12
Alnylam pharmaceuticals, inc.
2
Alstom
1
Alvotech lux holdings s.a.s.
5
Amgen inc.
4
Aon plc
1
Arcturus therapeutics holdings inc.
7
Arrowhead pharmaceuticals, inc.
4
Ascendis pharma a/s
1
Astellas pharma inc
1
Avalo therapeutics inc
1
Avid technology, inc.
1
Axcella health inc.
1
Baudax bio, inc.
1
Beigene, ltd.
1
Biogen inc.
5
Biontech se
3
Biotricity inc
1
Boston scientific corporation
1
Bridgeline digital, inc.
1
Bristol-myers squibb company
1
Campbell soup company
1
Cidara therapeutics, inc.
5
Encision inc
3
Fortive corporation
3
Genmab a/s
11
Halozyme therapeutics, inc.
2
Iveric bio, inc.
2
Johnson & johnson
248
Kamada ltd.
5
Kenvue inc.
6
Marinus pharmaceuticals, inc.
2
Meiragtx holdings plc
3
Milestone pharmaceuticals inc.
2
Neurocrine biosciences, inc.
3
Novartis ag
8
Orange
4
Ortho clinical diagnostics holdings plc
3
Protagonist therapeutics, inc.
6
Pulmatrix, inc.
4
Royalty pharma plc
13
Sanofi
9
Seagen inc.
2
Signature bank
2
Spectrum pharmaceuticals, inc.
2
Takeda pharmaceutical company limited
9
Teva pharmaceutical industries ltd
5
Titan medical inc.
2
Trinity biotech plc
2
Vir biotechnology, inc.
2
Vontier corporation
3
Xencor, inc.
3
Symbols
ABBV
92
AEM
51
ALNY
81
AMGN
55
APO
41
ARVL
199
AUY
47
BAM
54
BGNE
52
BMO
41
BMY
73
BNPQF
82
BNPQY
82
BNTX
55
BTG
44
CHRS
48
CYTK
44
DAO
46
ENB
42
FBIO
61
FNCTF
374
FRBA
95
GILD
55
GMAB
48
GOLD
50
INCY
77
IONS
43
JD
43
JKS
43
JNJ
248
LGND
46
LLY
219
LTUM
61
LXRX
41
MDT
45
MDWD
53
MPC
55
MPLX
53
MS
225
NEE
49
NEP
48
NTES
59
NVS
59
NVSEF
44
PAYD
198
PFE
64
PPRUF
89
PPRUY
89
PRVB
46
REGN
88
SNY
393
SNYNF
315
TAK
71
TEVJF
53
TK
49
TNK
48
TTOO
44
UAN
52
XNCR
42
XYF
104
Exchanges
Nasdaq
146
Nyse
248
Crawled Date
2024 - 03 - 21
2
2024 - 02 - 28
3
2024 - 02 - 15
2
2024 - 02 - 07
2
2023 - 11 - 29
2
2023 - 11 - 28
2
2023 - 11 - 08
3
2023 - 11 - 07
3
2023 - 11 - 02
3
2023 - 10 - 23
2
2023 - 10 - 22
2
2023 - 09 - 06
2
2023 - 08 - 03
3
2023 - 07 - 20
2
2023 - 07 - 18
3
2023 - 07 - 04
2
2023 - 05 - 09
2
2023 - 03 - 30
2
2023 - 03 - 29
2
2022 - 10 - 26
2
2022 - 10 - 18
2
2022 - 07 - 28
2
2022 - 04 - 27
2
2022 - 04 - 19
2
2022 - 03 - 29
2
2022 - 02 - 28
2
2022 - 02 - 16
2
2022 - 02 - 03
2
2021 - 11 - 12
2
2021 - 11 - 10
3
2021 - 11 - 09
2
2021 - 10 - 19
2
2021 - 08 - 31
2
2021 - 08 - 12
3
2021 - 08 - 11
4
2021 - 08 - 09
2
2021 - 08 - 05
3
2021 - 07 - 21
2
2021 - 07 - 08
2
2021 - 06 - 12
2
2021 - 05 - 24
2
2021 - 05 - 17
2
2021 - 05 - 11
4
2021 - 05 - 05
1
2021 - 05 - 03
1
2021 - 04 - 28
1
2021 - 04 - 22
1
2021 - 04 - 20
3
2021 - 04 - 13
1
2021 - 03 - 23
1
2021 - 03 - 22
1
2021 - 03 - 19
2
2021 - 03 - 18
1
2021 - 03 - 17
1
2021 - 03 - 11
1
2021 - 03 - 09
1
2021 - 03 - 08
1
2021 - 03 - 04
1
2021 - 01 - 26
3
2021 - 01 - 25
1
Crawled Time
00:00
9
01:00
4
05:00
4
06:00
6
07:00
6
08:00
5
08:20
3
09:00
6
10:00
5
11:00
30
12:00
32
12:07
1
12:15
3
12:20
7
12:30
6
13:00
16
13:15
1
13:20
3
13:30
4
14:00
12
14:15
1
14:20
3
14:30
1
15:00
7
15:15
2
15:20
2
16:00
5
16:20
2
17:00
11
18:00
4
19:00
2
20:00
14
20:01
1
20:20
4
21:00
12
22:00
10
23:00
4
Source
biotricity.com
1
investor.alkermes.com
5
ir.pulmatrix.com
2
ir.vistagen.com
1
spacfeed.com
2
www.admabiologics.com
1
www.biospace.com
97
www.globenewswire.com
94
www.halozyme.com
1
www.prnewswire.com
42
www.thehackettgroup.com
1
www.vbivaccines.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
results
symbols :
Jnj
save search
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published:
2024-04-19
(Crawled : 12:00)
- globenewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
2.88%
|
O:
0.83%
H:
1.35%
C:
1.2%
RPRX
|
$27.83
-1.17%
-1.19%
2.7M
|
Health Technology
|
0.96%
|
O:
1.07%
H:
1.22%
C:
1.11%
first
pharma
royalty
financial
results
Johnson & Johnson Reports Q1 2024 Results
Published:
2024-04-16
(Crawled : 12:00)
- biospace.com/
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
0.65%
|
O:
-2.09%
H:
0.0%
C:
0.0%
results
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
Published:
2024-04-04
(Crawled : 12:00)
- globenewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-5.48%
|
O:
-1.51%
H:
0.0%
C:
0.0%
TRIB
|
$1.8054
-3.87%
1.6K
|
Health Technology
|
-10.4%
|
O:
-0.99%
H:
2.0%
C:
2.0%
biotech
business
year
financial
results
Titan Medical Reports Fiscal Year 2023 Results
Published:
2024-03-29
(Crawled : 22:00)
- globenewswire.com
TMDI
|
News
|
$0.14
-26.32%
-35.52%
0
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
year
medical
results
Alto Neuroscience Reports Full Year 2023 Financial Results and Recent Business Highlights
Published:
2024-03-21
(Crawled : 22:00)
- biospace.com/
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-4.15%
|
O:
-0.03%
H:
0.0%
C:
0.0%
business
year
financial
results
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published:
2024-03-20
(Crawled : 00:00)
- biospace.com/
OABI
|
News
|
$4.69
0.43%
0.43%
300K
|
|
-11.2%
|
O:
-0.76%
H:
4.02%
C:
3.63%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-4.78%
|
O:
-0.65%
H:
0.0%
C:
0.0%
business
year
financial
results
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published:
2024-03-20
(Crawled : 20:00)
- globenewswire.com
ALVO
|
$13.32
0.76%
0.75%
180K
|
n/a
|
-12.48%
|
O:
-1.58%
H:
1.87%
C:
0.53%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-4.15%
|
O:
-0.03%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
-5.79%
|
O:
-0.89%
H:
0.0%
C:
0.0%
KMDA
|
$5.05
-0.99%
8K
|
Health Technology
|
-11.58%
|
O:
0.68%
H:
0.0%
C:
-1.86%
AMGN
|
News
|
$271.98
1.13%
1.12%
2.1M
|
Health Technology
|
-0.42%
|
O:
0.58%
H:
1.2%
C:
0.84%
business
year
update
financial
results
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
Published:
2024-03-14
(Crawled : 11:00)
- globenewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-8.22%
|
O:
-1.04%
H:
0.0%
C:
0.0%
ACIU
|
$2.425
2.75%
2.68%
210K
|
Health Technology
|
-34.59%
|
O:
1.89%
H:
0.0%
C:
-11.67%
year
update
financial
results
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
Published:
2024-03-11
(Crawled : 12:30)
- biospace.com/
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-6.18%
|
O:
0.43%
H:
0.0%
C:
0.0%
LEGN
|
News
|
$47.07
1.91%
1.87%
750K
|
Health Technology
|
-25.6%
|
O:
1.08%
H:
3.77%
C:
1.97%
biotech
year
results
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-28
(Crawled : 12:00)
- globenewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-6.81%
|
O:
0.67%
H:
0.0%
C:
0.0%
MRSN
|
$3.16
-2.77%
-2.85%
1.8M
|
Health Technology
|
-26.23%
|
O:
-5.39%
H:
24.13%
C:
20.05%
business
year
update
therapeutics
financial
results
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-02-27
(Crawled : 00:00)
- biospace.com/
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-7.8%
|
O:
-1.07%
H:
0.0%
C:
0.0%
PTGX
S
|
$26.6
3.87%
3.72%
300K
|
Health Technology
|
-9.89%
|
O:
0.3%
H:
1.25%
C:
-0.1%
year
update
financial
results
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-27
(Crawled : 00:00)
- biospace.com/
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-7.8%
|
O:
-1.07%
H:
0.0%
C:
0.0%
XNCR
|
$18.19
-1.03%
-1.04%
490K
|
Health Technology
|
-29.61%
|
O:
1.2%
H:
2.52%
C:
1.3%
year
financial
results
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
Published:
2024-02-21
(Crawled : 12:00)
- biospace.com/
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-4.9%
|
O:
0.8%
H:
0.0%
C:
0.0%
LIVN
|
$54.005
3.2%
3.1%
710K
|
Health Technology
|
-0.72%
|
O:
5.51%
H:
4.14%
C:
2.38%
results
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024
Published:
2024-02-15
(Crawled : 13:00)
- biospace.com/
MURA
|
$3.56
-0.28%
-0.28%
230K
|
|
-23.29%
|
O:
2.78%
H:
8.11%
C:
3.53%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-4.58%
|
O:
-0.19%
H:
1.6%
C:
1.24%
ALKS
|
$24.06
0.88%
0.87%
1.7M
|
Health Technology
|
-14.01%
|
O:
2.72%
H:
13.77%
C:
13.25%
year
financial
results
Royalty Pharma Reports Q4 and Full Year 2023 Results
Published:
2024-02-15
(Crawled : 12:30)
- globenewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-4.58%
|
O:
-0.19%
H:
1.6%
C:
1.24%
RPRX
|
$27.83
-1.17%
-1.19%
2.7M
|
Health Technology
|
-5.05%
|
O:
1.26%
H:
3.99%
C:
1.21%
pharma
year
royalty
results
Kenvue Reports Full Year and Fourth Quarter 2023 Results
Published:
2024-02-08
(Crawled : 12:30)
- biospace.com/
KVUE
4
|
$19.58
0.0%
17M
|
n/a
|
-4.58%
|
O:
-3.27%
H:
0.98%
C:
-2.62%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-5.64%
|
O:
-0.63%
H:
0.0%
C:
0.0%
year
results
Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine
Published:
2024-02-07
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-5.64%
|
O:
-0.63%
H:
0.0%
C:
0.0%
PTGX
S
|
$26.6
3.87%
3.72%
300K
|
Health Technology
|
4.72%
|
O:
-0.04%
H:
4.09%
C:
2.8%
jnj-2113
psoriasis
positive
results
study
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-07
(Crawled : 21:00)
- prnewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-4.04%
|
O:
-2.28%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-5.64%
|
O:
-0.63%
H:
0.0%
C:
0.0%
VNDA
|
$4.8
-6.07%
-6.46%
2.1M
|
Health Technology
|
38.87%
|
O:
0.27%
H:
20.82%
C:
11.51%
year
pharmaceuticals
financial
results
J&J Touts Positive Phase III Results for Antibody in Autoimmune Disorders
Published:
2024-02-06
(Crawled : 17:00)
- biospace.com/
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-4.72%
|
O:
-0.49%
H:
0.0%
C:
0.0%
antibody
positive
disorders
results
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
Published:
2024-01-30
(Crawled : 21:00)
- globenewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-6.58%
|
O:
0.49%
H:
0.14%
C:
-0.94%
RPRX
|
$27.83
-1.17%
-1.19%
2.7M
|
Health Technology
|
-3.0%
|
O:
0.07%
H:
0.44%
C:
-1.08%
pharma
year
royalty
financial
results
← Previous
1
2
3
4
5
6
7
8
9
…
12
13
Next →
Gainers vs Losers
75%
25%
Top 10 Gainers
MTTR
|
News
M
|
$4.78
174.71%
63.6%
72M
|
AGBA
|
$2.565
105.2%
51.27%
200M
|
Finance
MLEC
|
$2.44
74.29%
42.62%
78M
|
n/a
EDBL
|
News
|
$6.28
67.02%
40.13%
16M
|
ATGL
|
$2.91
48.81%
32.8%
180K
|
ZAPP
|
$0.2175
47.16%
32.05%
16M
|
n/a
ONFO
|
$0.6075
38.38%
27.74%
7.3M
|
n/a
VIVK
|
$1.48
38.32%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.8M
|
SDIG
A
|
$3.635
35.13%
26.0%
1M
|
Your saved searches
Save your searches and get alerts when important news are released.